Cerebral Venous Thrombosis Risk Up in Obese Women on OCPs

This article originally appeared here.
Share this content:
Cerebral Venous Thrombosis Risk Up in Obese Women on OCPs
Cerebral Venous Thrombosis Risk Up in Obese Women on OCPs

MONDAY, March 14, 2016 (HealthDay News) -- Obese women taking oral contraceptives may be nearly 30 times more likely to develop cerebral venous thrombosis (CVT), compared with women of normal weight who don't take birth control pills, according to a study published online March 14 in JAMA Neurology.

The study included 186 adult CVT patients, including men and women. Their strokes occurred from the mid-2000s through Dec. 31, 2014. The study also included a control group of 6,134 healthy adults. These adults had taken part in a large Dutch study conducted from 1999 to 2004. That study looked at risk factors for deep vein thrombosis and pulmonary embolism.

The researchers found that CVT patients were more often younger. Their median age was 40 compared to 48 for the control group. They were also more likely to have a history of cancer. And, they were more likely to be female and users of oral contraceptives. Obesity was associated with a nearly 30-fold increased risk of CVT, but only among women using oral contraceptives.

In a related editorial, Chirantan Banerjee, M.D., M.P.H., of the Medical University of South Carolina in Charleston, said that better counseling of obese women, including consideration of non-hormonal contraceptive options, "would be prudent."

Abstract
Full Text
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »